Sotagliflozin, also known as LX4211, is an orally active and a dual SGLT1/SGLT2 inhibitor, which improves glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
LPI (LP Information)' newest research report, the “Sotagliflozin Industry Forecast” looks at past sales and reviews total world Sotagliflozin sales in 2022, providing a comprehensive analysis by region and market sector of projected Sotagliflozin sales for 2023 through 2029. With Sotagliflozin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sotagliflozin industry.
This Insight Report provides a comprehensive analysis of the global Sotagliflozin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sotagliflozin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sotagliflozin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sotagliflozin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sotagliflozin.
The global Sotagliflozin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sotagliflozin players cover TargetMol, Clearsynth, Taiclone Biotech, MedKoo Biosciences, AbMole BioScience, CSN Pharm, Medchemexpress, Selleck Chemical and Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sotagliflozin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
TargetMol
Clearsynth
Taiclone Biotech
MedKoo Biosciences
AbMole BioScience
CSN Pharm
Medchemexpress
Selleck Chemical
Viatris
Sanofi
Mankind Pharma
Huikang Boyuan Chemical
Vcare Pharmatech
Prisun Pharmatech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sotagliflozin market?
What factors are driving Sotagliflozin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sotagliflozin market opportunities vary by end market size?
How does Sotagliflozin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Sotagliflozin Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Sotagliflozin by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Sotagliflozin by Country/Region, 2018, 2022 & 2029 2.2 Sotagliflozin Segment by Type 2.2.1 Purity ≥ 98 % 2.2.2 Purity ≥ 99 % 2.3 Sotagliflozin Sales by Type 2.3.1 Global Sotagliflozin Sales Market Share by Type (2018-2023) 2.3.2 Global Sotagliflozin Revenue and Market Share by Type (2018-2023) 2.3.3 Global Sotagliflozin Sale Price by Type (2018-2023) 2.4 Sotagliflozin Segment by Application 2.4.1 Research Institute 2.4.2 Pharmaceutical 2.4.3 Others 2.5 Sotagliflozin Sales by Application 2.5.1 Global Sotagliflozin Sale Market Share by Application (2018-2023) 2.5.2 Global Sotagliflozin Revenue and Market Share by Application (2018-2023) 2.5.3 Global Sotagliflozin Sale Price by Application (2018-2023) 3 Global Sotagliflozin by Company 3.1 Global Sotagliflozin Breakdown Data by Company 3.1.1 Global Sotagliflozin Annual Sales by Company (2018-2023) 3.1.2 Global Sotagliflozin Sales Market Share by Company (2018-2023) 3.2 Global Sotagliflozin Annual Revenue by Company (2018-2023) 3.2.1 Global Sotagliflozin Revenue by Company (2018-2023) 3.2.2 Global Sotagliflozin Revenue Market Share by Company (2018-2023) 3.3 Global Sotagliflozin Sale Price by Company 3.4 Key Manufacturers Sotagliflozin Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Sotagliflozin Product Location Distribution 3.4.2 Players Sotagliflozin Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Sotagliflozin by Geographic Region 4.1 World Historic Sotagliflozin Market Size by Geographic Region (2018-2023) 4.1.1 Global Sotagliflozin Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Sotagliflozin Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Sotagliflozin Market Size by Country/Region (2018-2023) 4.2.1 Global Sotagliflozin Annual Sales by Country/Region (2018-2023) 4.2.2 Global Sotagliflozin Annual Revenue by Country/Region (2018-2023) 4.3 Americas Sotagliflozin Sales Growth 4.4 APAC Sotagliflozin Sales Growth 4.5 Europe Sotagliflozin Sales Growth 4.6 Middle East & Africa Sotagliflozin Sales Growth 5 Americas 5.1 Americas Sotagliflozin Sales by Country 5.1.1 Americas Sotagliflozin Sales by Country (2018-2023) 5.1.2 Americas Sotagliflozin Revenue by Country (2018-2023) 5.2 Americas Sotagliflozin Sales by Type 5.3 Americas Sotagliflozin Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Sotagliflozin Sales by Region 6.1.1 APAC Sotagliflozin Sales by Region (2018-2023) 6.1.2 APAC Sotagliflozin Revenue by Region (2018-2023) 6.2 APAC Sotagliflozin Sales by Type 6.3 APAC Sotagliflozin Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Sotagliflozin by Country 7.1.1 Europe Sotagliflozin Sales by Country (2018-2023) 7.1.2 Europe Sotagliflozin Revenue by Country (2018-2023) 7.2 Europe Sotagliflozin Sales by Type 7.3 Europe Sotagliflozin Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Sotagliflozin by Country 8.1.1 Middle East & Africa Sotagliflozin Sales by Country (2018-2023) 8.1.2 Middle East & Africa Sotagliflozin Revenue by Country (2018-2023) 8.2 Middle East & Africa Sotagliflozin Sales by Type 8.3 Middle East & Africa Sotagliflozin Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Sotagliflozin 10.3 Manufacturing Process Analysis of Sotagliflozin 10.4 Industry Chain Structure of Sotagliflozin 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Sotagliflozin Distributors 11.3 Sotagliflozin Customer 12 World Forecast Review for Sotagliflozin by Geographic Region 12.1 Global Sotagliflozin Market Size Forecast by Region 12.1.1 Global Sotagliflozin Forecast by Region (2024-2029) 12.1.2 Global Sotagliflozin Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Sotagliflozin Forecast by Type 12.7 Global Sotagliflozin Forecast by Application 13 Key Players Analysis 13.1 TargetMol 13.1.1 TargetMol Company Information 13.1.2 TargetMol Sotagliflozin Product Portfolios and Specifications 13.1.3 TargetMol Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 TargetMol Main Business Overview 13.1.5 TargetMol Latest Developments 13.2 Clearsynth 13.2.1 Clearsynth Company Information 13.2.2 Clearsynth Sotagliflozin Product Portfolios and Specifications 13.2.3 Clearsynth Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Clearsynth Main Business Overview 13.2.5 Clearsynth Latest Developments 13.3 Taiclone Biotech 13.3.1 Taiclone Biotech Company Information 13.3.2 Taiclone Biotech Sotagliflozin Product Portfolios and Specifications 13.3.3 Taiclone Biotech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Taiclone Biotech Main Business Overview 13.3.5 Taiclone Biotech Latest Developments 13.4 MedKoo Biosciences 13.4.1 MedKoo Biosciences Company Information 13.4.2 MedKoo Biosciences Sotagliflozin Product Portfolios and Specifications 13.4.3 MedKoo Biosciences Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 MedKoo Biosciences Main Business Overview 13.4.5 MedKoo Biosciences Latest Developments 13.5 AbMole BioScience 13.5.1 AbMole BioScience Company Information 13.5.2 AbMole BioScience Sotagliflozin Product Portfolios and Specifications 13.5.3 AbMole BioScience Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 AbMole BioScience Main Business Overview 13.5.5 AbMole BioScience Latest Developments 13.6 CSN Pharm 13.6.1 CSN Pharm Company Information 13.6.2 CSN Pharm Sotagliflozin Product Portfolios and Specifications 13.6.3 CSN Pharm Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 CSN Pharm Main Business Overview 13.6.5 CSN Pharm Latest Developments 13.7 Medchemexpress 13.7.1 Medchemexpress Company Information 13.7.2 Medchemexpress Sotagliflozin Product Portfolios and Specifications 13.7.3 Medchemexpress Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Medchemexpress Main Business Overview 13.7.5 Medchemexpress Latest Developments 13.8 Selleck Chemical 13.8.1 Selleck Chemical Company Information 13.8.2 Selleck Chemical Sotagliflozin Product Portfolios and Specifications 13.8.3 Selleck Chemical Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Selleck Chemical Main Business Overview 13.8.5 Selleck Chemical Latest Developments 13.9 Viatris 13.9.1 Viatris Company Information 13.9.2 Viatris Sotagliflozin Product Portfolios and Specifications 13.9.3 Viatris Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Viatris Main Business Overview 13.9.5 Viatris Latest Developments 13.10 Sanofi 13.10.1 Sanofi Company Information 13.10.2 Sanofi Sotagliflozin Product Portfolios and Specifications 13.10.3 Sanofi Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Sanofi Main Business Overview 13.10.5 Sanofi Latest Developments 13.11 Mankind Pharma 13.11.1 Mankind Pharma Company Information 13.11.2 Mankind Pharma Sotagliflozin Product Portfolios and Specifications 13.11.3 Mankind Pharma Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Mankind Pharma Main Business Overview 13.11.5 Mankind Pharma Latest Developments 13.12 Huikang Boyuan Chemical 13.12.1 Huikang Boyuan Chemical Company Information 13.12.2 Huikang Boyuan Chemical Sotagliflozin Product Portfolios and Specifications 13.12.3 Huikang Boyuan Chemical Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Huikang Boyuan Chemical Main Business Overview 13.12.5 Huikang Boyuan Chemical Latest Developments 13.13 Vcare Pharmatech 13.13.1 Vcare Pharmatech Company Information 13.13.2 Vcare Pharmatech Sotagliflozin Product Portfolios and Specifications 13.13.3 Vcare Pharmatech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Vcare Pharmatech Main Business Overview 13.13.5 Vcare Pharmatech Latest Developments 13.14 Prisun Pharmatech 13.14.1 Prisun Pharmatech Company Information 13.14.2 Prisun Pharmatech Sotagliflozin Product Portfolios and Specifications 13.14.3 Prisun Pharmatech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Prisun Pharmatech Main Business Overview 13.14.5 Prisun Pharmatech Latest Developments 14 Research Findings and Conclusion